These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19269352)

  • 21. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression.
    Wong HK; Kammer GM; Dennis G; Tsokos GC
    J Immunol; 1999 Aug; 163(3):1682-9. PubMed ID: 10415075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of IL-27 in systemic lupus erythematosus.
    Pan HF; Tao JH; Ye DQ
    Expert Opin Ther Targets; 2010 May; 14(5):479-84. PubMed ID: 20350048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of CREB transcription factor in c-fos activation in natural killer cells.
    Ponti C; Gibellini D; Boin F; Melloni E; Manzoli FA; Cocco L; Zauli G; Vitale M
    Eur J Immunol; 2002 Dec; 32(12):3358-65. PubMed ID: 12432566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity.
    Herndon TM; Juang YT; Solomou EE; Rothwell SW; Gourley MF; Tsokos GC
    Clin Immunol; 2002 May; 103(2):145-53. PubMed ID: 12027419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of regulatory T cells in systemic lupus erythematosus.
    Gerli R; Nocentini G; Alunno A; Bocci EB; Bianchini R; Bistoni O; Riccardi C
    Autoimmun Rev; 2009 Mar; 8(5):426-30. PubMed ID: 19185065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus.
    Juang YT; Rauen T; Wang Y; Ichinose K; Benedyk K; Tenbrock K; Tsokos GC
    J Biol Chem; 2011 Jan; 286(3):1795-801. PubMed ID: 21097497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ICER/CREM-mediated transcriptional attenuation of IL-2 and its role in suppression by regulatory T cells.
    Bodor J; Fehervari Z; Diamond B; Sakaguchi S
    Eur J Immunol; 2007 Apr; 37(4):884-95. PubMed ID: 17372992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. cAMP response element modulator α controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus.
    Hedrich CM; Crispin JC; Rauen T; Ioannidis C; Apostolidis SA; Lo MS; Kyttaris VC; Tsokos GC
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16606-11. PubMed ID: 23019580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antisense cyclic adenosine 5'-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus.
    Tenbrock K; Juang YT; Gourley MF; Nambiar MP; Tsokos GC
    J Immunol; 2002 Oct; 169(8):4147-52. PubMed ID: 12370343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging concepts in the molecular pathogenesis of systemic lupus erythematosus.
    Nambiar MP; Juang YT; Tsokos GC
    Arch Immunol Ther Exp (Warsz); 2002; 50(1):35-45. PubMed ID: 11916307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered signal transduction in SLE T cells.
    Tenbrock K; Juang YT; Kyttaris VC; Tsokos GC
    Rheumatology (Oxford); 2007 Oct; 46(10):1525-30. PubMed ID: 17586862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-23: a promising therapeutic target for systemic lupus erythematosus.
    Leng RX; Pan HF; Chen GM; Wang C; Qin WZ; Chen LL; Tao JH; Ye DQ
    Arch Med Res; 2010 Apr; 41(3):221-5. PubMed ID: 20682181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-10 blockade corrects impaired in vitro cellular immune responses of systemic lupus erythematosus patients.
    Lauwerys BR; Garot N; Renauld JC; Houssiau FA
    Arthritis Rheum; 2000 Sep; 43(9):1976-81. PubMed ID: 11014347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-18 activity in systemic lupus erythematosus.
    Favilli F; Anzilotti C; Martinelli L; Quattroni P; De Martino S; Pratesi F; Neumann D; Beermann S; Novick D; Dinarello CA; Boraschi D; Migliorini P
    Ann N Y Acad Sci; 2009 Sep; 1173():301-9. PubMed ID: 19758166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin 2, T cell receptor and sex hormone studies in autoimmune mice.
    Talal N; Dang H; Ahmed SA; Kraig E; Fischbach M
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():21-5. PubMed ID: 3112377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. cAMP-responsive element modulator (CREM)α protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus.
    Hedrich CM; Rauen T; Tsokos GC
    J Biol Chem; 2011 Dec; 286(50):43429-36. PubMed ID: 21976679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How signaling and gene transcription aberrations dictate the systemic lupus erythematosus T cell phenotype.
    Crispín JC; Kyttaris VC; Juang YT; Tsokos GC
    Trends Immunol; 2008 Mar; 29(3):110-5. PubMed ID: 18249583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
    Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
    Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of Tax and PKA-mediated expression of HTLV-I promoter via cAMP response element binding and modulator proteins CREB and CREM.
    Bodor J; Walker W; Flemington E; Spetz AL; Habener JF
    FEBS Lett; 1995 Dec; 377(3):413-8. PubMed ID: 8549766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-2 abnormalities in systemic lupus erythematosus and rheumatoid arthritis. A role for overproduction of interleukin-2 in human autoimmunity?
    Warrington RJ
    J Rheumatol; 1988 Apr; 15(4):616-20. PubMed ID: 3260951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.